For the first time the orthopedic stem cell market was the fastest growing orthopedic biomaterial segment.
With the proper consideration and a clear understanding of what you value in a CRO, it is possible to develop an outsourcing strategy that can get your product to market more efficiently and with greater evidence to support it.
A recent survey of industry professionals found that the medical device market is growing increasingly competitive, emphasizing the need for high-quality clinical trial data.
The site was a joint effort between the FDA, the National Institutes of Health (NIH) and the National Library of Medicine (NLM).
To identify the ideal CRO to meet the imaging needs of your trial, it is important to involve them at the very beginning of the process.
Serving a more cost-conscious group of providers has impacted the device design process in many ways.
According to a a study published in the journal in the journal Stem Cells Translational Medicine, researchers may have found a new protocol to grow and transform human embryonic stem cells into cartilage cells.
A team of researchers have developed a means of producing strong and durable bio-based polyurethane that could help contain costs and improve device function.
There are at least two efforts underway that could eventually serve as a substitute for the human meniscus.
Recently, an executive of medical device manufacturer B. Braun Medical Inc. made the case for the tax’s repeal at a Senate Finance Committee (Subcommittee on Health Care) hearing.
The 21st Century Cures Act aims to make a number of significant changes to the design and regulation of medical device clinical trials.
Leadless pacemakers represent an exciting new frontier for cardiac devices.
